Condition

Recurrent Nasopharyngeal Carcinoma clinical trials and research

• 7Clinical trials
• 6Countries

Newest Recurrent Nasopharyngeal Carcinoma clinical trials

All recruiting trials (7)

• Intensity-modulated proton therapy for recurrent nasopharyngeal cancer

  This will try intensity-modulated proton radiotherapy to treat adults with unresectable recurrent nasopharyngeal cancer and may reduce severe side effects from repeat radiation.

  Recruiting at 2 sites Guangzhou Concord Cancer Center · Guangzhou, Guangdong and 1 other locations · NCT07412314

• Comparing neoadjuvant and adjuvant therapies for recurrent nasopharyngeal carcinoma

  This study is testing whether giving treatment before surgery or after surgery helps people with recurrent nasopharyngeal cancer do better.

  Recruiting at 2 sites Phase 3 Eye & ENT Hospital of Fudan University · Shanghai, Shanghai Municipality and 6 other locations · NCT06235203

• Comparing adjuvant therapy to surgery alone for early-stage recurrent nasopharyngeal carcinoma

  This study is testing if adding chemotherapy and immunotherapy after surgery helps people with early-stage recurrent nasopharyngeal carcinoma do better than just having surgery alone.

  Recruiting at 3 sites Phase 3 Eye & ENT Hospital of Fudan University · Shanghai, Shanghai Municipality and 6 other locations · NCT06228079

• Adding a new drug to immunotherapy for advanced nasopharyngeal cancer

  This study is testing if adding a new drug to standard immunotherapy can help people with advanced nasopharyngeal cancer live longer and feel better after their initial treatment.

  Recruiting at 83 sites Phase 2 National Cancer Institute (NCI) · Dublin, California and 94 other locations · NCT06029270

• Low-temperature plasma radiofrequency ablation versus high-frequency electrocautery resection for localized recurrent nasopharyngeal carcinoma

  This trial will see if low-temperature plasma radiofrequency ablation works better than high-frequency electrocautery resection for adults with localized recurrent nasopharyngeal carcinoma.

  Recruiting at 3 sites Sun Yat-sen University · Guangzhou, Guangdong and 2 other locations · NCT04425265

• Using Toripalimab with Chemoradiotherapy for Recurrent Nasopharyngeal Carcinoma

  This study is testing if adding a new drug called Toripalimab to standard chemotherapy and radiation can help people with recurrent nasopharyngeal cancer live longer and feel better during treatment.

  Recruiting Phase 3 Cancer Hospital of Guangxi Medical University · Nanning, Guangxi · NCT04376866

• Combining PD-1 antibody with chemoradiotherapy for recurrent nasopharyngeal carcinoma

  This study is testing if adding a PD-1 antibody to standard chemoradiotherapy can help people with recurrent nasopharyngeal carcinoma feel better compared to just using chemoradiotherapy alone.

  Recruiting at 5 sites Phase 3 Sun Yat-sen University · Guangzhou, Guangdong and 11 other locations · NCT03907826

Related topics

Quick answers

How many Recurrent Nasopharyngeal Carcinoma clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (6 trials), Australia (1 trial), Canada (1 trial), Hong Kong (1 trial), Singapore (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →